Morningstar Investor users sign in here.

Company Profile

  • Business description

    Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

  • Contact

    2265 Upper Middle Road East
    Suite 602
    Oakville ON L6H 0G5
    CAN

    T: +1 289 910-0850

    E: trevor.burns@cardiolrx.com

    https://www.cardiolrx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2024

    Employees

    17

Stocks News & Analysis

video

Our view of Australian banks

Our latest banking industry pulse explored the state of the industry.
stocks

Our top opportunities in the asset manager sector

Signs of stabilisation, but competitive positioning still weakening against passive investments.
stocks

How to assess a company’s debt load

BHP is used as an example to show how to assess the impact of too much debt on financial risk and flexibility.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,008.70 41.50 -0.52%
CAC 40 8,010.83 12.91 -0.16%
DAX 40 17,930.32 24.16 -0.13%
Dow JONES (US) 37,983.24 475.84 -1.24%
FTSE 100 7,995.58 71.78 0.91%
HKSE 16,721.69 373.34 -2.18%
NASDAQ 16,175.09 267.10 -1.62%
Nikkei 225 39,038.46 485.09 -1.23%
NZX 50 Index 11,811.40 119.92 -1.01%
S&P 500 5,123.41 75.65 -1.46%
S&P/ASX 200 7,753.00 35.10 -0.45%
SSE Composite Index 3,019.47 0.00 0.00%

Market Movers

Name
Last price
Change
% Change
Sayona Mining Ltd SYA 0.04 0.00 -2.56%
South32 Ltd S32 3.41 0.12 3.50%
The Star Entertainment Group Ltd SGR 0.48 0.03 -4.95%
Droneshield Ltd DRO 0.97 0.12 13.45%
Genex Power Ltd GNX 0.27 0.00 0.94%
Imugene Ltd IMU 0.09 0.00 1.63%
Piedmont Lithium Inc PLL 0.26 0.05 24.39%
Red 5 Ltd RED 0.42 0.02 -3.49%
Zip Co Ltd ZIP 1.30 0.05 -3.53%
Pantoro Ltd PNR 0.08 0.00 -5.36%